trial · primary record
Mitapivat
Pediatric Pyruvate Kinase Deficiency
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-01 |
| Primary endpoint | Percentage of Participants Achieving a Hemoglobin (Hb) Response |
| Registry ID | NCT05175105 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:58.017Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05175105
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mitapivat · compound